These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27293195)

  • 1. [Recurrences in Clostridium difficile infections in cancer patients].
    García-Lozano T; Aznar-Oroval E; Martín-Utrilla S
    Med Clin (Barc); 2016 Nov; 147(9):417-418. PubMed ID: 27293195
    [No Abstract]   [Full Text] [Related]  

  • 2. Fecal Microbiota Transplantation for Primary Clostridium difficile Infection.
    Juul FE; Garborg K; Bretthauer M; Skudal H; Øines MN; Wiig H; Rose Ø; Seip B; Lamont JT; Midtvedt T; Valeur J; Kalager M; Holme Ø; Helsingen L; Løberg M; Adami HO
    N Engl J Med; 2018 Jun; 378(26):2535-2536. PubMed ID: 29860912
    [No Abstract]   [Full Text] [Related]  

  • 3. Clostridium difficile disease and vancomycin--questionable clinical superiority.
    Tarchini G
    Clin Infect Dis; 2011 Jul; 53(2):212. PubMed ID: 21690637
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Clostridium difficile disease in patients not responding to metronidazole.
    Kapoor S
    J Infect; 2008 May; 56(5):394-5. PubMed ID: 18410968
    [No Abstract]   [Full Text] [Related]  

  • 5. Clostridium difficile and Entamoeba histolytica infections in patients with colitis in the Philippines.
    Warren CA; Labio E; Destura R; Sevilleja JE; Jamias JD; Daez ML
    Trans R Soc Trop Med Hyg; 2012 Jul; 106(7):424-8. PubMed ID: 22657531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin "telephone".
    Drekonja DM
    Clin Infect Dis; 2011 Jul; 53(2):211-2. PubMed ID: 21690636
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on: Increasing incidence of community-associated atypical Clostridium difficile disease in children.
    Pant C; Bass PF
    Clin Pediatr (Phila); 2010 Sep; 49(9):907; author reply 908. PubMed ID: 20693524
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical inquiries. What are effective therapies for Clostridium difficile-associated diarrhea?
    Ohl ME; Stevermer JJ; Meadows S; Tribuna J; Chek K
    J Fam Pract; 2005 Feb; 54(2):176-8. PubMed ID: 15689297
    [No Abstract]   [Full Text] [Related]  

  • 9. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile Infection and Patient-Specific Antimicrobial Resistance Testing Reveals a High Metronidazole Resistance Rate.
    Barkin JA; Sussman DA; Fifadara N; Barkin JS
    Dig Dis Sci; 2017 Apr; 62(4):1035-1042. PubMed ID: 28116592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile infection in the "oldest" old: clinical outcomes in patients aged 80 and older.
    Cober ED; Malani PN
    J Am Geriatr Soc; 2009 Apr; 57(4):659-62. PubMed ID: 19392957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuation of antibiotics is associated with failure of metronidazole for Clostridium difficile-associated diarrhea.
    Modena S; Gollamudi S; Friedenberg F
    J Clin Gastroenterol; 2006 Jan; 40(1):49-54. PubMed ID: 16340634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.
    Bouza E; Alcalá L; Marín M; Valerio M; Reigadas E; Muñoz P; González-Del Vecchio M; de Egea V
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1777-1786. PubMed ID: 28501926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative treatments for Clostridium difficile disease: what really works?
    McFarland LV
    J Med Microbiol; 2005 Feb; 54(Pt 2):101-111. PubMed ID: 15673502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifaximin in the treatment of recurrent Clostridium difficile infection.
    Mattila E; Arkkila P; Mattila PS; Tarkka E; Tissari P; Anttila VJ
    Aliment Pharmacol Ther; 2013 Jan; 37(1):122-8. PubMed ID: 23095030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
    Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
    J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fucidic acid use in metronidazole nonresponders with Clostridium difficile infection.
    Bektaş M; Toruner M; Cetinkaya H; Soykan I; Ozden A
    Digestion; 2007; 75(4):177-8. PubMed ID: 17687186
    [No Abstract]   [Full Text] [Related]  

  • 18. C-reactive protein is a useful predictor of metronidazole treatment failure in mild-to-moderate Clostridium difficile infection.
    Farne HA; Martin NK; Main J; Orchard T; Tyrrell-Price J
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):33-6. PubMed ID: 23026925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low risk of Clostridium difficile infections in hospitalized patients with inflammatory bowel disease in a German tertiary referral center.
    Ott C; Girlich C; Klebl F; Plentz A; Iesalnieks I; Schölmerich J; Obermeier F
    Digestion; 2011; 84(3):187-92. PubMed ID: 21646782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating C. difficile.
    Parmar MS
    CMAJ; 2005 Feb; 172(4):448; author reply 448. PubMed ID: 15710921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.